The table below shows Krystal Biotech, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$116.36M
$97.80M
$96.04M
$88.18M
$83.84M
$70.28M
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$15.33M
$14.59M
$14.41M
$14.26M
$13.51M
$15.58M
SG&A
KRYS annual revenue (10-K history)
Krystal Biotech, Inc. reported annual revenue of $389.13M for fiscal year 2025. That is up 33.9% from $290.51M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.
